Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population

Clinical Cancer Research

Volumn 10, Issue 24, 2004, Pages 8380-8385

  Chen, Yi Ding ^a   Zheng, Shu ^b   Yu, Jie Kai ^b   Hu, Xun ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PLASMA PROTEIN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BLOOD ANALYSIS; COLORECTAL CANCER; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN MICROARRAY; SURFACE ENHANCED LASER DESORPTION IONIZATION MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PROTEINS; CA-19-9 ANTIGEN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 11144233952     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1162-03     Document Type: Article

References (23)

1. Li LD, Lu FZ, Zhang SW. Analysis of variation trend and short term detection of Chinese malignant tumor mortality during twenty years. Chin J Oncol 1997;19:3-9.
2. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK, editors. SEER cancer statistics review, 1973-1995. Bethesda, MD: National Cancer Institute; 1998.
3. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986;104:66-73.
4. Yu H, Zheng S, Cai XH. Evaluation of RPHA fecal occult blood test in screening for colorectal cancer. J Chin Oncol 1990;12:108-10.
5. Frattini M, Balestra D, Pilotti S, Bertario L, Pierotti MA. Tumor location and detection of k-ras mutations in stool from colorectal cancer patients. J Natl Cancer Inst (Bethesda) 2003;95:72-3.
6. Dong SM, Traverse G, Johnson C, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (Bethesda) 2001;93:858-65.
7. Merchant M, Weinberger SR. Recent advancements in surface enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000;21:1164-77.
8. Kuwata H, Yip TT, Yip CL, Tomita M, Hutchens TW. Bactericidal domain of lactoferrin: detection, quantitation and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Comm 1998;245:764-73.
9. Qu Y, Adam BL, Yasui Y, et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem 2002;48:1835-43.
10. Adam BL, Qu YS, Davis JW, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-14.
11. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
12. Romualdi C, Campanaro S, Campagna D, et al. Pattern recognition in gene expression profiling using DNA array: a comparative study of different statistical methods applied to cancer classification. Hum Mol Genet 2003;12:823-36.
13. Ball G, Mian S, Holding F, et al. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics 2002;18:395-404.
14. Møller MF. A scaled conjugate gradient algorithm for fast supervised learning. Neural Netw 1993;6:525-33.
15. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approached for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48:1296-304.
16. Khan J, Wei JS, Ringner M, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001;7:658-9.
17. Kornek GV, Depisch D, Rosen HR, Temsch EM, Scheithauer W. Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies. J Cancer Res Clin Oncol 1992;118:318-20.
18. Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am 1994;8:533-53.
19. Ohuchi N, Takahashi K, Matoba N, et al. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients. Jpn J Clin Oncol 1989;19:242-50.
20. Ueda T, Shimada E, Urakawa T. The clinicopathologic features of serum CA 19-9-positive colorectal cancers. Surg Today 1994;24:518-25.
21. Midgley R, Kerr D. Colorectal cancer. Lancet 1999;353:391-9.
22. Wilkins MR, Sanchez JC, Gooley AA, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Gen Eng Rev 1995;13:19-50.
23. Pandey A, Mann M. Proteomics to study genes and genomes. Nature (Lond) 2000;405:837-46.